Syringaresinol attenuates Tau phosphorylation and ameliorates cognitive dysfunction induced by sevoflurane in aged rats
Journal of Neuropathology & Experimental Neurology · 2024
DOI: 10.1093/jnen/nlae026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, 2024. Verfasst von Simin Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shannxi, China. Hauptthemen laut MEDLINE: Sevoflurane, tau Proteins, Rats, Sprague-Dawley, Cognitive Dysfunction. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cognitive dysfunction following anesthesia with agents such as sevoflurane is a significant clinical problem, particularly in elderly patients. This study aimed to explore the protective effects of the phytochemical syringaresinol (SYR) against sevoflurane-induced cognitive deficits in aged Sprague-Dawley rats and to determine the underlying mechanisms involved. We assessed the impact of SYR on sevoflurane-induced cognitive impairment, glial activation, and neuronal apoptosis through behavioral tests (Morris water maze), immunofluorescence, Western blotting for key proteins involved in apoptosis and inflammation, and enzyme-linked immunosorbent assays for interleukin-1β, tumor necrosis factor-α, and interleukin-6. SYR treatment mitigated sevoflurane-induced cognitive decline, reduced microglial and astrocyte activation (decreased Iba-1 and GFAP expression), and countered neuronal apoptosis (reduced Bax, cleaved-caspase3, and cleaved-PARP expression). SYR also enhanced Sirtuin-1 (SIRT1) expression and reduced p-Tau phosphorylation; these effects were reversed by the SIRT1 inhibitor EX527. SYR exerts neuroprotective effects on sevoflurane-induced cognitive dysfunction by modulating glial activity, apoptotic signaling, and Tau phosphorylation through the SIRT1 pathway. These findings could inform clinical strategies to safeguard cognitive function in patients undergoing anesthesia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shannxi, China.
- Department of Anesthesia and Comfort Health Center, Xi'an International Medical Center Hospital, Xi'an, Shannxi, China.
Zitieren
APA
Zheng, S., Teng, Y., Liu, H., He, J., Zhang, S., & Xiong, H. (2024). Syringaresinol attenuates Tau phosphorylation and ameliorates cognitive dysfunction induced by sevoflurane in aged rats. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlae026
Vancouver
Zheng S, Teng Y, Liu H, He J, Zhang S, Xiong H. Syringaresinol attenuates Tau phosphorylation and ameliorates cognitive dysfunction induced by sevoflurane in aged rats. Journal of Neuropathology & Experimental Neurology. 2024. doi:10.1093/jnen/nlae026
BibTeX
@article{Zheng2024,
author = {Zheng, Simin and Teng, Yunpeng and Liu, Hongtao and He, Jiaxuan and Zhang, Shaobo and Xiong, Hongfei},
title = {Syringaresinol attenuates Tau phosphorylation and ameliorates cognitive dysfunction induced by sevoflurane in aged rats},
journal = {Journal of Neuropathology & Experimental Neurology},
year = {2024},
doi = {10.1093/jnen/nlae026}
}
EUVIMED